The pooled HR for OS provided in nine studies indicated that Ki-67 expression was associated with worse survival in BC patients (HR = 2.03, 95% CI 1.31–3.16; P = 0.002), with heterogeneity (I2 = 80%, P < 0.0001; S4 Fig and Table 1). The gene discussed is MKI67; the disease is breast cancer.